Evidence map›Paper›PMID 41826793›Full record

ArticleBioinformatics (Oxford, England)2026

Beyond blacklists: a critical assessment of exclusion set generation strategies and alternative approaches.

Brydon P G Wall, Jonathan D Ogata, My Nguyen, Amy L Olex, Konstantinos V Floros, Anthony C Faber, Joseph L McClay, J Chuck Harrell, Mikhail G Dozmorov

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Brydon P G WallDepartment of Biostatistics, Virginia Commonwealth University, Richmond, VA 23298, United States.
Jonathan D OgataDepartment of Biostatistics, Virginia Commonwealth University, Richmond, VA 23298, United States.
My NguyenDepartment of Biostatistics, Virginia Commonwealth University, Richmond, VA 23298, United States.
Amy L OlexC. Kenneth and Diane Wright Center for Clinical and Translational Research, Virginia Commonwealth University, Richmond, VA 23298, United States.
Konstantinos V FlorosVCU Philips Institute, Virginia Commonwealth University School of Dentistry and Massey Comprehensive Cancer Center, Richmond, VA 23298, United States.ORCID 0000-0003-4916-2257
Anthony C FaberVCU Philips Institute, Virginia Commonwealth University School of Dentistry and Massey Comprehensive Cancer Center, Richmond, VA 23298, United States.
Joseph L McClayDepartment of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University, Richmond, VA 23298, United States.ORCID 0000-0002-3628-2447
J Chuck HarrellDepartment of Pathology, Virginia Commonwealth University, Richmond, VA 23284, United States.ORCID 0000-0003-3541-8418
Mikhail G DozmorovDepartment of Biostatistics, Virginia Commonwealth University, Richmond, VA 23298, United States.ORCID 0000-0002-0086-8358

Funding

Wright Regional Center for Clinical and Translational ScienceUM1TR004360 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI FREDERICK Gerard MOELLER · 2023 to 2026
$16.3M
United for Health Excellence - Living PDX Program (U4HELPP)U54CA283762 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Devanand Sarkar · 2023 to 2026
$5.0M
SUMOylation disruption is toxic for SS18-SSX-driven synovial sarcomaR01CA272710 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Anthony Charles Faber · 2023 to 2026
$2.2M
Circumventing acquired carboplatin resistance in triple-negative breast cancersR01CA246182 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI HARRELL, JOSHUA (CHUCK) · 2020 to 2024
$1.9M
Characterization of metastasis models derived from breast cancer patients of African descentR21CA273779 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI HARRELL, JOSHUA (CHUCK) · 2022 to 2023
$395k
Network analysis of CNS transcription factors implicated in psychiatric disordersR56MH107879 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI MCCLAY, JOSEPH LOUIE · 2018 to 2018
$388k
CTSA UM1TR004360George and Lavinia Blick Research ScholarshipNCATS NIH HHS UM1 TR004360NCI NIH HHS 1R01CA272710-01A1NCI NIH HHS R01 CA246182NCI NIH HHS R01 CA272710NCI NIH HHS R21 CA273779NCI NIH HHS U54 CA283762NIH HHS HT9425-23-1-1017NIH HHS R56 MH107879NIH/NCI R01CA246182NIH/NCI R21CA273779NIH/NCI U54CA283762NIMH NIH HHS R56 MH107879
6 · The paper itself

Abstract

motivationShort-read sequencing data can be affected by alignment artifacts in certain genomic regions. Removing reads overlapping these exclusion regions, previously known as Blacklists, help to potentially improve biological signal. Alternatively, "sponge" or decoy sequences have been proposed to reduce alignment artifacts.

resultsWe examined the widely used Blacklist software and found that pre-generated exclusion sets were difficult to reproduce due to sensitivity to input data, aligner choice, and read length. We further explored the use of "sponge" sequences-unassembled genomic regions such as satellite DNA, ribosomal DNA, and mitochondrial DNA-as an alternative approach. We additionally investigated the effect of the T2T-CHM13 genome assembly on improving biological signals. Aligning reads to a genome that includes sponge sequences reduced signal correlation in ChIP-seq data comparably to Blacklist-derived exclusion sets while preserving biological signal. Sponge-based alignment also had minimal impact on RNA-seq gene counts, suggesting broader applicability beyond chromatin profiling. These results highlight the limitations of fixed exclusion sets, and recommend the use of the T2T-CHM13 assembly or, for the hg38 genome assembly, "sponge" sequences as an alignment-guided strategy for reducing artifacts and improving functional genomics analyses.

Indexed as

GenomicsSequence AlignmentSequence Analysis, DNASoftwareAnimalsHigh-Throughput Nucleotide Sequencing

Identifiers

PMID41826793
PMCPMC13020910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.